|
| |
ArteriosclerosisDownload PDF containing detailed information.
Recent Publications on Arteriosclerosis: |  |
Bronchial Arteries: An Arteriosclerosis-Resistant Circulation.
Background: Until now, it is unknown whether and to what extent... | 13th November, 2009
| Department of Cardiothoracic Surgery, 401 General Military Hospital of
| Respiration. 2009 Nov 10.
DOI Direct Link |
Accelerated arteriosclerosis: a form of transplant arteriopathy.
PURPOSE OF REVIEW: Terminology for posttransplant renal arterial lesions... | 10th November, 2009
| aDepartment of Pathology, Hopital Europeen Georges Pompidou, France
| Curr Opin Organ Transplant. 2009 Nov 5.
DOI Direct Link |
Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.
BACKGROUND: The oxidized LDL-particles (oxLDL) are considered to be an... | 10th November, 2009
| IKFE-Institute for Clinical Research and Development, Mainz, Germany.
| Clin Lab. 2009;55(7-8):275-81.
|
Arteriosclerosis and Atherosclerosis. Guilty by Association.
BACKGROUND: The oxidized LDL-particles (oxLDL) are considered to be an... | 4th November, 2009
| Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's
| Hypertension. 2009 Nov 2.
DOI Direct Link |
Impact of acute exercise on antioxidant enzymes activity and lipid status in blood of patients with hypertension.
BACKGROUND/AIM: Many studies support the hypothesis that oxidative stress... | 3rd November, 2009
| University Clinical Centre "Dr Dragisa Misovic-Dedinje", Department of
| Vojnosanit Pregl. 2009 Sep;66(9):695-9.
|
→View more research publications. |
Press Releases About Arteriosclerosis:
|
 |
| Isis and Collaborators Present New Research at the ATVB Annual Conference |
1st May, 2009 |
Isis Pharmaceuticals, Inc. |
WASHINGTON and CARLSBAD, Calif., May 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Isis and collaborators presented data on numerous advanced programs from
|
| VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque |
1st May, 2009 |
VIA Pharmaceuticals, Inc. |
Data Presented at American Heart Association ATVB Conference Shows Reduction in Non-Calcified Plaque Volume and Fewer New Plaque Lesions in Treated Patients
WASHINGTON and SAN FRANCISCO, May 1
|
| Resverlogix Provides Quarterly Update |
28th April, 2009 |
Resverlogix Corp. |
Alzheimer's disease biomarker assessment to be added to the
Phase 1b/2a trial
TSX Exchange Symbol: RVX
CALGARY, April 28 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix
|
| VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 |
31st March, 2009 |
VIA Pharmaceuticals, Inc. |
Data from ACS Phase 2 MDCT Sub-study to be Released Concurrent with AHA Presentation
SAN FRANCISCO, March 31 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology
|
BioPortfolio Ltd. offers e-mail and postal lists for Arteriosclerosis scientists - we have details of around 6660 individuals working on Arteriosclerosis .
This page has been viewed 358 times
Recent Search Terms used to find this page: data for occurrence arteriosclerosis 2009 | Smoking and other risk factors of cardiovascular diseases connected with arteriosclerosis among youth | arteriosclerosis medical imaging | arterioesclerosis USA | arteriosclerosus | epilactose | epilactose | latest arteriosclerosis research | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Arteriosclerosis across BioPortfolio, or for Arteriosclerosis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
